tiprankstipranks
Company Announcements

Nuwellis Reveals Aquadex System Success in Liver Disease

Nuwellis Reveals Aquadex System Success in Liver Disease

Nuwellis (NUWE) has released an update.

Discover the Best Stocks and Maximize Your Portfolio:

Nuwellis, Inc. has announced significant findings showing the effectiveness of their Aquadex SmartFlow® system for patients with severe liver disease experiencing fluid overload. The press release detailing these results emphasizes the system’s potential benefits, marking a noteworthy development in the treatment of end-stage liver disease related complications.

For further insights into NUWE stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1